Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment
PATHOLOGY RESEARCH AND PRACTICE, vol.214, no.9, pp.1291-1296, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 214 Issue: 9
- Publication Date: 2018
- Doi Number: 10.1016/j.prp.2018.07.010
- Journal Name: PATHOLOGY RESEARCH AND PRACTICE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1291-1296
- Keywords: Non-small cell lung cancer (NSCLC), Carbonic anhydrase IX (CA DC), Neoadjuvant treatment, Prognosis, Overall survival, Disease free survival, POOR-PROGNOSIS, GENE-EXPRESSION, CA-IX, HYPOXIA, RADIOTHERAPY, CARCINOMA, PLASMA
- Istanbul University Affiliated: Yes
Abstract
Background: To assess the prognostic importance of carbonic anhydrase IX (CA IX), a hypoxic biomarker, after neoadjuvant treatment in Stage III non-small cell lung cancer (NSCLC) patients.